Working Parties
What is the EBMT?Related Meetings EBMT logo
MembershipRegistryWorking PartiesNurses GroupDirectoryTransplant GuidelinesCorporate Sponsorship
Chronic Leukaemia
Prospective Clinical Trials
Retrospective Studies
Members
Publications
Questionnaire
Study Administration
MMVAR

A randomized controlled study of Velcade (Bortezomib) plus Thalidomide plus Dexamethasone compared to Thalidomide plus Dexamethasone for the treatment of myeloma patients progressing or relapsing after autologous transplantation.

Trial management center:

Trial Co-ordination:

EBMT Clinical Trials Office London

Trial Co-ordinator:
Georgia Bullock
(Tel: +44-207-188-8404)

Data Management:
Menno van den Bosch

(Tel: +31-71-526-9727)

Coordinating investigator:
Laurent Garderet (Paris)

Statistician:
Simona Iacobelli
(Rome)

 

Click on the links below to download relevant documents in format

 

 


What is the EBMT? | Related Meetings | Membership | Registry | Working Parties
Nurses Group | Directory | Transplant Guidelines | Corporate Sponsorship

HOME | SITE MAP | RELATED LINKS | CONTACT US